149 (PB029) - Omomyc as a novel therapeutic strategy against metastatic triplenegative breast cancer, alone and in combination with the standard of care
| Autor: | Giuntini, F., Massó-Vallés, D., González-Larreategui, Í., Thabussot, H., Kaur, J., Zacarías-Fluck, M., Casacuberta-Serra, S., Martínez-Martín, S., Foradada-Felip, L., Serrano, E., Martín-Fernández, G., Castillo Cano, V., López-Estévez, S., Serra, V., Whitfield, J., Beaulieu, M.E., Soucek, L. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2022 174 Supplement 1:S53-S54 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect